Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2007 August;55(4) > Minerva Cardioangiologica 2007 August;55(4):491-6





A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752




Minerva Cardioangiologica 2007 August;55(4):491-6

language: English

Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers

Palazzuoli A., Iovine F., Gallotta M., Nuti R.

Unit of Cardiology Department of Internal Medicine and Metabolic Diseases S. Maria alle Scotte Hospital University of Siena, Siena, Italy


Brain natriuretic peptides (BNP and pro-BNP) represent useful biomarkers in heart failure diagnosis and risk stratification; more recently their clinical use has been applied to acute coronary syndrome with and without ST segment elevation. Few studies have demonstrated that hormone dosage can add clinical and prognostic information with respect to the traditional laboratory analysis (i.e. troponin, MB-creatinkinase, C-reactive protein). Besides these traditional biomarkers, growing data indicate potential laboratory indexes that can predict endothelial dysfunction, vascular thrombosis and platelet aggregation. However, their prognostic value is currently unknown. We describe the most widely used laboratory tools in coronary artery disease with potential prognostic power that could provide incremental predictive information in clinical practice.

top of page

Publication History

Cite this article as

Corresponding author e-mail